ResMed Inc. (RME)
Summary
RME Chart
The IRS Makes You Sell Whether the Market Is Up or Down. These 3 ETFs Fund the RMD Without Touching a Share
Turning 73 changes the math on your retirement account. The IRS no longer lets your traditional IRA compound in peace.
ResMed Q4 Earnings Call Highlights
ResMed NYSE: RMD reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share rose 16% to $2.95, while the company expanded gross margin despite continued inflation in electronic components and freight.
RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y
Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.
ResMed Inc. (RME) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has ResMed Inc. ever had a stock split?
ResMed Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Michael J. Farrell CEO | XMUN Exchange | US7611521078 ISIN |
| US Country | 11,370 Employees | 20 Aug 2026 Last Dividend | 31 Aug 2010 Last Split | 2 Jun 1995 IPO Date |
Overview
ResMed Inc. is a pioneering company focused on developing, manufacturing, distributing, and marketing medical devices alongside cloud-based software applications tailored for the healthcare markets. With its operational base divided between Sleep and Respiratory Care, and Software as a Service (SaaS), ResMed is at the forefront of offering innovative solutions for managing respiratory disorders. The company's extensive product lineup and software solutions cater to both medical and consumer needs, aiming to improve patient outcomes through advanced technology and connectivity. Founded in 1989 and headquartered in San Diego, California, ResMed markets its products globally through a combination of direct sales forces and a network of distributors, targeting sleep clinics, home healthcare dealers, and hospitals.
Products and Services
- Technologies for Respiratory Disorders - ResMed offers an array of products for treating various respiratory disorders, including ventilation devices, diagnostic products, and mask systems for use in hospitals and homes. These products are complemented by headgear, accessories, and dental devices, integrating cutting-edge technology for both medical and consumer applications.
- Cloud-Based Software Informatics - The company's software solutions, such as AirView and myAir, facilitate remote monitoring and management of patient outcomes. AirView allows healthcare professionals to remotely monitor and adjust patients' device settings, while myAir, a personalized therapy management app, supports patients with sleep apnea through education, troubleshooting tools, and engagement strategies to improve compliance.
- U-Sleep Compliance Monitoring - U-Sleep is a solution designed to help home medical equipment (HME) providers streamline their sleep programs by efficiently monitoring patient compliance, an essential factor for successful therapy outcomes.
- Out-of-Hospital Software Solutions - ResMed provides various software solutions like Brightree, MatrixCare, HEALTHCAREfirst, and MEDIFOX DAN, catering to the business management and caregiving needs of HME providers, pharmacies, senior living facilities, skilled nursing facilities, and hospice organizations. These solutions include business management software, electronic health records, billing, coding services, and analytics, facilitating improved care delivery and operational efficiency.
